These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3924252)

  • 21. [Acute kidney insufficiency in an alcoholic patient with liver cirrhosis].
    Räz HR; Moch H; Wagner P
    Schweiz Med Wochenschr; 1996 Jul; 126(30):1306-13. PubMed ID: 8765771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pathogenesis and therapy of ascites in liver cirrhosis].
    Dölle W
    Internist (Berl); 1966 Jan; 7(1):48-54. PubMed ID: 4861685
    [No Abstract]   [Full Text] [Related]  

  • 23. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 25. Urea for Chronic Hyponatremia.
    Rondon-Berrios H
    Blood Purif; 2020; 49(1-2):212-218. PubMed ID: 31851974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined furosemide and human albumin treatment for diuretic-resistant edema.
    Elwell RJ; Spencer AP; Eisele G
    Ann Pharmacother; 2003 May; 37(5):695-700. PubMed ID: 12708949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of hyponatremia with edema].
    Nakamura K; Kurokawa K
    Naika; 1969 Dec; 24(6):1025-30. PubMed ID: 5360068
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of diuretics in heart failure and cirrhosis.
    Schrier RW
    Semin Nephrol; 2011 Nov; 31(6):503-12. PubMed ID: 22099507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A; Bancons J; Dubarry JJ
    Bord Med; 1972 Oct; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract]   [Full Text] [Related]  

  • 32. [Management of life threatening diuretic-resistant ascites by ultrafiltration and reinfusion of the ascitic fluid after dialysis].
    Kara J; Wórum I; Csornal A; Középesy L
    Orv Hetil; 1989 Jul; 130(28):1497-9. PubMed ID: 2748167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of dialytic ultrafiltration and peritoneal reinfusion in the management of diuretic resistant ascites.
    Raju SF; Achord JL
    Am J Gastroenterol; 1984 Apr; 79(4):308-12. PubMed ID: 6711532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tropical hyponatremia: role of tropical climate in diuretic therapy.
    Shah CP; Shukla DN; Shah NV
    J Assoc Physicians India; 1968 Nov; 16(11):843-52. PubMed ID: 5713488
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis.
    Decaux G; Cauchie P; Soupart A; Kruger M; Delwiche F
    Br Med J (Clin Res Ed); 1986 Dec; 293(6561):1534-6. PubMed ID: 3099945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and biological study of a new diuretic: E 103 E].
    Plauchu M; Bourlier V; Meunier P
    Lyon Med; 1968 Jan; 219(4):275-8 passim. PubMed ID: 5664959
    [No Abstract]   [Full Text] [Related]  

  • 37. [Decompensation].
    Møller S; Henriksen JH
    Ugeskr Laeger; 1998 Jan; 160(5):654-5. PubMed ID: 9470474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential Effectiveness of Tolvaptan to Improve Ascites Unresponsive to Standard Diuretics and Overall Survival in Patients with Decompensated Liver Cirrhosis.
    Yamada T; Ohki T; Hayata Y; Karasawa Y; Kawamura S; Ito D; Kojima K; Seki M; Toda N; Tagawa K
    Clin Drug Investig; 2016 Oct; 36(10):829-35. PubMed ID: 27405984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced alcoholic cirrhosis: a case report.
    LeFebvre J; Butina M
    Clin Lab Sci; 2007; 20(2):80-3. PubMed ID: 17557706
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
    Sakaida I; Yamashita S; Kobayashi T; Komatsu M; Sakai T; Komorizono Y; Okada M; Okita K;
    J Int Med Res; 2013 Jun; 41(3):835-47. PubMed ID: 23685892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.